Entrada Therapeutics Inc (TRDA : NASDAQ)
Common Stock
$6.89
USD
+0.00 (%)
Last updated: 2026-09-17
Get TRDA alerts:
TRDA
Entrada Therapeutics Inc
WealthAwesomePerformance
1 Day
+0.15%
1 Week
-3.09%
1 Month
-5.87%
YTD
+1.17%
Key Statistics
Market Cap
$268.27M
52W High
$16.45
52W Low
$5.08
P/E Ratio
-
50 Day MA
$6.99
200 Day MA
$9.60
Beta
-0.25
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $6.91 | $7.05 | $6.67 | $6.90 | $6.90 | 297,364 |
| 9/16/2026 | $6.92 | $6.99 | $6.74 | $6.89 | $6.89 | 249,216 |
| 9/15/2026 | $7.05 | $7.05 | $6.67 | $6.88 | $6.88 | 247,765 |
| 9/14/2026 | $6.80 | $7.07 | $6.72 | $7.05 | $7.05 | 336,096 |
| 9/11/2026 | $6.49 | $6.81 | $6.29 | $6.80 | $6.80 | 291,808 |
| 9/10/2026 | $7.00 | $7.17 | $6.38 | $6.42 | $6.42 | 448,100 |
| 9/9/2026 | $7.47 | $7.55 | $7.02 | $7.11 | $7.11 | 382,000 |
| 9/8/2026 | $7.02 | $7.70 | $6.95 | $7.52 | $7.52 | 514,200 |
| 9/4/2026 | $7.11 | $7.17 | $7.00 | $7.13 | $7.13 | 341,700 |
| 9/3/2026 | $7.31 | $7.42 | $7.04 | $7.17 | $7.17 | 395,600 |
Analyst Price Targets
Based on 4 analysts covering TRDA · as of Sep 17, 2026
Wall Street analysts forecast TRDA stock price to rise 175.8% over the next 12 months.
Consensus
Strong Buy4.50 / 5.00
Avg. Target
US$19.00
+175.8% Upside
Current Price
US$6.89
Last close
Analyst Breakdown (4 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TRDA's historical volatility
30-Day Vol
66.2%
Annualized
90-Day Vol
67.7%
Annualized
Trend (90d)
-20.2%
Annualized drift
90d Mean
US$6.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$6.74 | US$5.36 – US$8.46 |
| 60 trading days | US$6.58 | US$4.76 – US$9.08 |
| 90 trading days | US$6.42 | US$4.32 – US$9.54 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Entrada Therapeutics Inc
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Financials
- Revenue (TTM)
- $4.69M
- EBITDA
- $-170.86M
- Profit Margin
- 0.00%
- ROE (TTM)
- -54.10%
- EPS (Diluted)
- -3.96
- Book Value
- 7.52
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About TRDA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |